The Journal of Pediatrics
Volume 149, Issue 5, Supplement , Pages S69-S73, November 2006

Effects of age and mineral intake on the regulation of iron absorption in infants

Presented as part of a symposium recognizing the 25th anniversary of the Bristol-Myers Squibb Freedom to Discover Nutrition Grants Program held June 7-8, 2005 at the University of Cincinnati, Cincinnati, OH.

  • Shannon L. Kelleher, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Shannon L. Kelleher, PhD, Department of Nutrition, University of California, Davis, One Shields Avenue, Meyer Hall 3135, Davis, CA 95616.

Department of Nutrition, University of California, Davis

Received 14 April 2006; accepted 1 June 2006.

Iron deficiency anemia during infancy is associated with delayed psychomotor and cognitive development; thus there is global interest in improving infant iron status through iron supplementation programs early in life. In adults, iron homeostasis primarily is controlled through regulatory changes in iron absorption; however, there is little understanding of mechanisms that regulate iron absorption in infants. As iron stores become depleted from rapid hemoglobin expansion, ontogenic transition to regulated iron absorption must occur. To elucidate age-dependent mechanisms regulating intestinal iron absorption and homeostasis in human infants, studies in suckling rat pups indicated that increased divalent metal transporter 1 (DMT1), ferroportin 1 (FPN1), and hephaestin expression and changes in localization within the enterocyte may direct the ontogenic regulation of iron homeostasis mechanisms. Unlike observations in adults, iron absorption, DMT1, and FPN1 expression were not affected by iron intake during mid-infancy, similar to observations in human infants. Interestingly, at this age supplemental iron was retained in the small intestine, but only in pups that were not previously iron deficient. Although intestinal retention may possibly help limit excess iron absorption, decreased linear growth, head circumference, and weight gain has been observed in iron-supplemented, nonanemic human infants, suggesting that global iron supplementation programs should be approached with caution.

Abbreviation: DMT1, Divalent metal transporter 1, FPN1, Ferroportin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-3476(06)00615-9

doi:10.1016/j.jpeds.2006.06.055

The Journal of Pediatrics
Volume 149, Issue 5, Supplement , Pages S69-S73, November 2006